Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

918 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
Fragoulis GE, Dey M, Zhao S, Schoones J, Courvoisier D, Galloway J, Hyrich KL, Nikiphorou E. Fragoulis GE, et al. Among authors: galloway j. RMD Open. 2022 Nov;8(2):e002726. doi: 10.1136/rmdopen-2022-002726. RMD Open. 2022. PMID: 36323488 Free PMC article. Review.
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).
Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A; B S R B R Control Centre Consortium; Symmons DP; BSR Biologics Register. Dixon WG, et al. Among authors: galloway j. Ann Rheum Dis. 2010 Mar;69(3):522-8. doi: 10.1136/ard.2009.118935. Epub 2009 Oct 22. Ann Rheum Dis. 2010. PMID: 19854715 Free PMC article.
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.
Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP; BSRBR Control Centre Consortium; British Society for Rheumatology Biologics Register. Galloway JB, et al. Rheumatology (Oxford). 2011 Jan;50(1):124-31. doi: 10.1093/rheumatology/keq242. Epub 2010 Jul 31. Rheumatology (Oxford). 2011. PMID: 20675706 Free PMC article.
The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Watson KD, Lunt M; BSRBR Control Centre Consortium; Symmons DP; British Society for Rheumatology Biologics Register. Galloway JB, et al. Rheumatology (Oxford). 2011 Jul;50(7):1341-2. doi: 10.1093/rheumatology/ker146. Epub 2011 Apr 12. Rheumatology (Oxford). 2011. PMID: 21489973 No abstract available.
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.
Davies R, Galloway JB, Watson KD, Lunt M, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register. Davies R, et al. Ann Rheum Dis. 2011 Oct;70(10):1831-4. doi: 10.1136/ard.2011.153536. Epub 2011 Jul 22. Ann Rheum Dis. 2011. PMID: 21784722 Free PMC article.
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
Mercer LK, Green AC, Galloway JB, Davies R, Lunt M, Dixon WG, Watson KD; British Society for Rheumatology Biologics Register Control Centre Consortium; Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register. Mercer LK, et al. Ann Rheum Dis. 2012 Jun;71(6):869-74. doi: 10.1136/annrheumdis-2011-200622. Epub 2012 Jan 12. Ann Rheum Dis. 2012. PMID: 22241900 Free PMC article.
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Galloway JB, Mercer LK, Moseley A, Dixon WG, Ustianowski AP, Helbert M, Watson KD, Lunt M, Hyrich KL, Symmons DP. Galloway JB, et al. Ann Rheum Dis. 2013 Feb;72(2):229-34. doi: 10.1136/annrheumdis-2011-201108. Epub 2012 Apr 24. Ann Rheum Dis. 2013. PMID: 22532633 Free PMC article.
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.
Mercer LK, Davies R, Galloway JB, Low A, Lunt M, Dixon WG, Watson KD, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium. Mercer LK, et al. Rheumatology (Oxford). 2013 Jan;52(1):91-8. doi: 10.1093/rheumatology/kes350. Rheumatology (Oxford). 2013. PMID: 23238979 Free PMC article.
The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA.
Závada J, Lunt M, Davies R, Low AS, Mercer LK, Galloway JB, Watson KD, Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium. Závada J, et al. Among authors: galloway jb. Ann Rheum Dis. 2014 Jan;73(1):252-5. doi: 10.1136/annrheumdis-2012-203102. Epub 2013 May 5. Ann Rheum Dis. 2014. PMID: 23644671
918 results